|
|
 |
| |
 |
|
|
|
|
Leveraging the Expertise of Our Partners
Over the years, BioMarin
has grown its business and product pipeline independently
as well as through strategic partnerships with individuals,
research institutions and companies that offer complementary
vision and expertise. By partnering with others
who are like-minded, we hold the potential to better
address the medical needs of a greater number of
individuals located around the world.
The following are some of our current partners companies. We invite you to learn more about these partnerships by visiting other pages on this section of the website.
Genzyme Corporation:
| • |
For the development and commercialization
of Aldurazyme® (laronidase) for
MPS I |
|
Alliant Pharmaceuticals:
| • |
For the North American commercialization
of the Orapred product line, including
Orapred ODT ™ (prednisolone soduim phosphate
orally disintegrating tablets) |
|
Merck Serono:
| •
|
For the development and
ex-U.S./ ex-Japan/ ex-Canada commercialization
(pending regulatory approvals) of BioMarin’s
Kuvan and 6R-BH4 for other indications |
|
If you are interested in establishing a strategic partnership with BioMarin, please contact our Business Development group at bd@bmrn.com. |
|
| |
|
|
| |
|
|
|
